EVRYSDI cpr pel 5 mg 28 pce

7680699190010 CH-69919 M09AX10 01.99.0.
EVRYSDI cpr pel 5 mg 28 pce
EVRYSDI cpr pel 5 mg 28 pce
EVRYSDI cpr pel 5 mg 28 pce
1 / 3
google

Details

Product number
6991901
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
risdiplamum 5 mg, acidum tartaricum, mannitolum, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, aromatica (Erdbeere) cum maltodextrinum et E 1450, natrii stearylis fumaras corresp. natrium 0.22 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto.

Articles (1)

Evrysdi 5 mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/06/2025
Patient information leaflet
Français
10/06/2025
Patient information leaflet
Italien
10/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.22 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
69919
Drug name
Evrysdi, Filmtabletten
Galenic form
FILM
ATC Code
M09AX10
Authorization status
Z
Dispensation category
A
First authorization
27/05/2025
Authorization expiration date
26/05/2030
IT number
01.99.0.
Domain
Human medicine
Field of application
Spinale Muskelatrophie

Packaging details

Description (FR)
EVRYSDI cpr pel 5 mg 28 pce
Description (DE)
EVRYSDI Filmtabl 5 mg 28 Stk
Market launch
27/05/2025
Narcotic (BTM)
No